These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34486381)

  • 1. Atrial fibrillation management during septal myectomy for hypertrophic cardiomyopathy: A systematic review.
    Seco M; Lau JC; Medi C; Bannon PG
    Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):98-107. PubMed ID: 34486381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
    Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
    Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Cox-Maze IV and Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Bakir NH; MacGregor RM; Khiabani AJ; Musharbash FN; Schill MR; Sinn LA; Schuessler RB; Melby SJ; Gleva MJ; Damiano RJ
    Ann Thorac Surg; 2022 Jan; 113(1):109-117. PubMed ID: 33662312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach.
    Hodges K; Tang A; Rivas CG; Umana-Pizano J; Chemtob R; Desai MY; Gillinov AM; Smedira N; Wierup P
    J Card Surg; 2020 Nov; 35(11):2957-2964. PubMed ID: 33111447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Boll G; Rowin EJ; Maron BJ; Wang W; Rastegar H; Maron MS
    Am J Cardiol; 2020 Jan; 125(1):120-126. PubMed ID: 31727261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Kharbanda RK; Ramdat Misier NL; Van den Eynde J; El Mathari S; Tomšič A; Palmen M; Klautz RJM
    Int J Cardiol; 2023 Sep; 387():131099. PubMed ID: 37263356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Meng Y; Zhang Y; Liu P; Zhu C; Lu T; Hu E; Yang Q; Nie C; Wang S
    Front Cardiovasc Med; 2021; 8():720950. PubMed ID: 34409083
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.
    Lapenna E; Pozzoli A; De Bonis M; La Canna G; Nisi T; Nascimbene S; Vicentini L; Di Sanzo S; Del Forno B; Schiavi D; Alfieri O
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1112-1118. PubMed ID: 28329110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy.
    Song C; Wang S; Guo Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    BMC Cardiovasc Disord; 2019 May; 19(1):122. PubMed ID: 31117937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent atrial flutter after radiofrequency ablation for atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy undergoing repetitive transcoronary ablation of septal hypertrophy.
    Cheng L; Wang N; Dai L; Ding H; Geng Z; Son Y
    BMC Cardiovasc Disord; 2024 Oct; 24(1):532. PubMed ID: 39358714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation.
    Pecha S; Ghandili S; Hakmi S; Willems S; Reichenspurner H; Wagner FM
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):294-298. PubMed ID: 28964598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of substrate modification in catheter ablation of paroxysmal atrial fibrillation: pulmonary vein isolation alone or with complex fractionated electrogram ablation.
    Nam GB; Jin ES; Choi H; Song HG; Kim SH; Kim KH; Hwang ES; Park KM; Kim J; Rhee KS; Choi KJ; Kim YH
    Tex Heart Inst J; 2012; 39(3):372-9. PubMed ID: 22719147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure.
    Suzuki K; Miyamoto K; Ueda N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Noda T; Nagase S; Aiba T; Yambe T; Kakuta T; Tadokoro N; Fukushima S; Fujita T; Kusano K
    Heart Vessels; 2021 May; 36(5):675-685. PubMed ID: 33580804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.
    Dinshaw L; Münkler P; Schäffer B; Klatt N; Jungen C; Dickow J; Tamenang A; Schleberger R; Pecha S; Pinnschmidt H; Patten M; Reichenspurner H; Willems S; Meyer C
    J Am Heart Assoc; 2021 Feb; 10(3):e017451. PubMed ID: 33455428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation.
    McGilvray MMO; Bakir NH; Kelly MO; Perez SC; Sinn LA; Schuessler RB; Zemlin CW; Maniar HS; Melby SJ; Damiano RJ
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2884-2894. PubMed ID: 34041815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Centre Experience of Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy.
    Afanasyev AV; Bogachev-Prokophiev AV; Ovcharov MA; Pivkin AN; Zalesov AS; Budagaev SA; Sharifulin RM; Zheleznev SI; Karaskov AM
    Heart Lung Circ; 2020 Jun; 29(6):949-955. PubMed ID: 31427226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.